Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)

Market Cap	2.45B
Revenue (ttm)	999.18M
Net Income (ttm)	66.20M
Shares Out	n/a
EPS (ttm)	0.89
PE Ratio	37.06
Forward PE	n/a
Dividend	0.61 (1.88%)
Ex-Dividend Date	Dec 27, 2024

Volume	n/a
Average Volume	11
Open	32.40
Previous Close	31.80
Day's Range	32.40 - 32.40
52-Week Range	29.60 - 39.20
Beta	n/a
RSI	57.71
Earnings Date	May 9, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, coolin...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 3,615
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KOY

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial numbers in JPY